Pharma Grade CBD Products to be Rescheduled

By |2018-09-29T00:06:18+00:00Sep,18 29|Categories: Medical Cannabis|Tags: , , , , , , , , |

Pharma Grade CBD Products to be Rescheduled to Schedule V Pharma Grade CBD Products such as Epidiolex will be Schedule V - comparable to codeine-containing cough syrups - indicating a low potential for abuse and effectiveness as a therapeutic drug. The Drug Enforcement Agency published a notification on the FDA CBD rescheduling in the Federal Register. "With [...]

CBD Isolate Drugs Rescheduled by the FDA

By |2018-09-28T06:03:43+00:00Sep,18 28|Categories: CBD|Tags: , , , , , , , , , |

CBD Isolate Drugs Rescheduled by the FDA CBD isolate based drug Epidolex has been removed from Schedule I and placed in Schedule V which will make access to the drug much simpler for patients who can afford it. The rescheduling is a major breakthrough in the medical cannabis and hemp CBD industry because it finally recognises [...]